Recap: Genmab Q1 Earnings

Genmab (NASDAQ:GMAB) reported its Q1 earnings results on Wednesday, May 10, 2023 at 11:00 AM.

Here's what investors need to know about the announcement.

Genmab missed estimated earnings by 92.31%, reporting an EPS of $0.05 versus an estimate of $0.65.

Revenue was up $91.68 million from the same period last year.

Last quarter the company missed on EPS by $3.06 which was followed by a 1.58% drop in the share price the next day.

Here's a look at Genmab's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	3.18	1.63	1.58
EPS Actual	0.12	0.53	0.41	0.11
Revenue Estimate	664.17M	475.35M	404.75M	319.59M
Revenue Actual	699.51M	553.75M	453.01M	319.67M

To track all earnings releases for Genmab visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

To add Benzinga News as your preferred source on Google, click here.